1. Home
  2. NRXP vs KIRK Comparison

NRXP vs KIRK Comparison

Compare NRXP & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • KIRK
  • Stock Information
  • Founded
  • NRXP 2015
  • KIRK 1966
  • Country
  • NRXP United States
  • KIRK United States
  • Employees
  • NRXP N/A
  • KIRK N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • KIRK Diversified Commercial Services
  • Sector
  • NRXP Health Care
  • KIRK Miscellaneous
  • Exchange
  • NRXP Nasdaq
  • KIRK Nasdaq
  • Market Cap
  • NRXP 32.6M
  • KIRK 26.7M
  • IPO Year
  • NRXP N/A
  • KIRK 2002
  • Fundamental
  • Price
  • NRXP $3.38
  • KIRK $1.18
  • Analyst Decision
  • NRXP Strong Buy
  • KIRK Buy
  • Analyst Count
  • NRXP 4
  • KIRK 2
  • Target Price
  • NRXP $28.50
  • KIRK $4.50
  • AVG Volume (30 Days)
  • NRXP 267.4K
  • KIRK 232.4K
  • Earning Date
  • NRXP 08-13-2025
  • KIRK 09-04-2025
  • Dividend Yield
  • NRXP N/A
  • KIRK N/A
  • EPS Growth
  • NRXP N/A
  • KIRK N/A
  • EPS
  • NRXP N/A
  • KIRK N/A
  • Revenue
  • NRXP N/A
  • KIRK $431,111,000.00
  • Revenue This Year
  • NRXP N/A
  • KIRK N/A
  • Revenue Next Year
  • NRXP N/A
  • KIRK N/A
  • P/E Ratio
  • NRXP N/A
  • KIRK N/A
  • Revenue Growth
  • NRXP N/A
  • KIRK N/A
  • 52 Week Low
  • NRXP $1.10
  • KIRK $1.05
  • 52 Week High
  • NRXP $6.01
  • KIRK $2.50
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 58.54
  • KIRK 52.81
  • Support Level
  • NRXP $2.90
  • KIRK $1.16
  • Resistance Level
  • NRXP $3.53
  • KIRK $1.23
  • Average True Range (ATR)
  • NRXP 0.20
  • KIRK 0.05
  • MACD
  • NRXP -0.03
  • KIRK 0.01
  • Stochastic Oscillator
  • NRXP 76.19
  • KIRK 72.22

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: